Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pseudo C2 Symmetric Chiral Diallyl Compound. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114105822A reveals high-yield iridium-catalyzed synthesis of pseudo-C2 symmetric chiral diallyl compounds, offering superior enantioselectivity for pharmaceutical and agrochemical manufacturing.